Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Assessment of mechanisms of tumour necrosis factor alpha (TNF-alpha) inhibitors' action in rheumatoid arthritis female patients

2013/09/N/NZ5/00815

Keywords:

Rheumatoid arthritis tumour necrosis factor alpha inhibitors glycosaminoglycans biomarkers of cartilage turnover biomarkers of bone turnover biomarkers of vascular endothelial dysfunction

Descriptors:

  • NZ5_3: Pathogenesis of human diseases
  • NZ5_5: Diagnostics in human diseases
  • NZ5_7: Human disease treatment

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

woj. śląskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Anna Szeremeta 

Number of co-investigators in the project: 3

Call: PRELUDIUM 5 - announced on 2013-03-15

Amount awarded: 149 889 PLN

Project start date (Y-m-d): 2014-03-03

Project end date (Y-m-d): 2018-03-02

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (4)
  • Articles in post-conference publications (1)
  • Book publications / chapters in book publications (1)
  1. Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors
    Authors:
    Szeremeta A, Jura-Półtorak A, Zoń-Giebel A, Kopeć-Mędrek M, Kucharz EJ, Olczyk K
    Academic press:
    Journal of Clinical Medicine (rok: 2020, tom: 9, strony: 45311), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jcm9051377 - link to the publication
  2. Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
    Authors:
    Szeremeta A, Jura-Półtorak A, Koźma EM, Głowacki A, Kucharz EJ, Kopeć-Mędrek M, Olczyk K
    Academic press:
    Arthritis Research & Therapy (rok: 2018, tom: 20, strony: 45301), Wydawca: BioMed Central
    Status:
    Published
    DOI:
    10.1186/s13075-018-1711-z - link to the publication
  3. Aggrecan turnover in women with rheumatoid arthritis treated with TNF-α inhibitors
    Authors:
    Szeremeta A, Jura-Półtorak A, Zoń-Giebel A, Kopeć-Mędrek M, Kucharz EJ, Olczyk K
    Academic press:
    Arthritis Research & Therapy , Wydawca: BioMed Central
    Status:
    Submitted
  4. The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis
    Authors:
    Szeremeta A, Jura-Półtorak A, Komosińska-Vassev K, Zoń-Giebel A, Kapołka D, Olczyk K
    Academic press:
    Scandinavian Journal of Rheumatology (rok: 2016, tom: 24, strony: 45300), Wydawca: Taylor & Francis Group
    Status:
    Published
    DOI:
    10.1080/03009742.2016.1203020 - link to the publication
  1. Ocena dynamiki zmian stężenia C-końcowego propeptydu prokolagenu typu I we krwi kobiet chorych na reumatoidalne zapalenie stawów leczonych inhibitorami TNF-α
    Authors:
    Jura-Półtorak A, Szeremeta A, Olczyk K
    Conference:
    XXIII Naukowy Zjazd Polskiego Towarzystwa Farmaceutycznego, Farmacja w Polsce perspektywy nauki i zawodu (rok: 2017, ), Wydawca: Polskie Towarzystwo Farmaceutyczne
    Data:
    konferencja 19-22.09.2017
    Status:
    Published
  1. Ocena biomarkerów obrotu kolagenu typu II we krwi kobiet z reumatoidalnym zapaleniem stawów leczonych inhibitorami TNF-α
    Authors:
    Miśkiewicz J, Suchanek-Solowska K, Szeremeta A, Jura-Półtorak A
    Book:
    Choroby XXI wieku - najnowsze doniesienia. Tom 2. (rok: 2019, tom: 2, strony: 158-184), Wydawca: Lublin : Wydawnictwo Naukowe Tygiel Sp. z o. o.
    Status:
    Published